DBV Tech - DBVT Net earnings per share for the last four quarters

Public company logo of DBV Technologies S.A. (DBVT)

DBV Technologies S.A. (DBVT) is developing cost-effective Viaskin patches for production, which will ensure high profitability following FDA approval. Physicians value the brand as a reliable developer of safe therapies for children with allergies. Serving as the primary valuation tool, this price chart captures the indicator at 42.80. The company is currently spending its cash reserves as planned while awaiting the completion of regulatory reviews for its products.

DBVT: DBV Tech Net earnings per share (EPS TTM) 02/11/2024 - 11/14/2026

Financial and market metric breakdowns for DBV Technologies SA (DBVT)

- current quotes and average value forecast:
Stock Price DBV Technologies S.A.|DBVT - Analyst Consensus Forecast
- issuer market value details:
Market Capitalization DBV Tech|DBVT - Total Company Value
- book value of equity indicators:
Equity per Share DBV Technologies|DBVT - Book Capitalization|Capitalization to Book Value Ratio dbv-technologies.com|DBVT - Company Total Assets
- debt and liquidity data:
Debt to Equity DBV Technologies S.A.|DBVT - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity DBV Technologies S.A.|DBVT - Company Total Debt|Debt to Net Assets Ratio DBV Tech|DBVT - Company Long-Term Liabilities|Amount of Current Liabilities DBV Technologies|Immediate Liquidity dbv-technologies.com
- earnings and valuation multiples information:
DBVT - Net Profit|Future Profit DBV Technologies S.A.|DBVT - P/E Multiple|Future Price to Earnings Multiple DBV Technologies S.A.|DBVT - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation DBV Tech|DBVT - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months DBV Technologies|DBVT - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months dbv-technologies.com|DBVT - Earnings per share growth in current year|Expected net earnings per share growth next year DBV Technologies S.A.
- sales and revenue indicators:
DBVT - Revenue and Sales Volume|Company Sales Forecast DBV Technologies S.A.|DBVT - P/S Multiple|Market Cap to Expected Sales Ratio DBV Tech
Fundamental valuation:DBV Technologies DBVT
Flagship merchandise of DBV Technologies S.A.

This indicator measures the percentage change in net earnings per share over a rolling four-quarter period relative to the same period last year. By analyzing the EPS TTM YoY trend on the GURU.Markets platform, an investor can isolate seasonal fluctuations from the true trend of business efficiency. Growth in this metric confirms the monetization of intellectual property and patent protection. For DBV Technologies S.A. (DBVT), this reflects a transition from development to extracting marginal rent from its clinical platform.

Direct competitors

KRYS - Net earnings per share (EPS TTM)|APGE: Net earnings per share (EPS TTM)|ARQT - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Vericel Corp.|Earnings per share for the last 12 months ORKA (Oruka Pharma)|Net earnings per share (EPS TTM) SMTI|solesence.com - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) DERM (Journey Medical Corporation)|Forte Biosciences Inc. - Earnings per share for the last twelve months|EMPG: Net earnings per share for the last 12 months|SLGL: Earnings per share for the last twelve months|AXIL (reviveprocare.com) - Net earnings per share for the last 12 months|medicuspharma.com - Earnings per share for the trailing year|Net earnings per share for the last 12 months VRCA|HOTH (Hoth) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) BFRI|VYNE - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) SNOA (Sonoma Pharmaceuticals, Inc.)|QNRX - Net earnings per share for the last 12 months|Azitra - Net earnings per share (EPS TTM)|Earnings per share for the trailing year DRMA (Dermata Therapeutics Inc)|Elevai Skincare (ELAB) - Earnings per share for the last twelve months|Earnings per share for the last 12 months RVNC